The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Protease Inhibitors from Marine Actinobacteria as a Potential Source for Antimalarial Compound
Open accessAbstract
The study was planned to screen the marine actinobacterial extract for the protease inhibitor activity and its anti- Pf activity under in vitro and in vivo conditions. Out of 100 isolates, only 3 isolates exhibited moderate to high protease inhibitor activities on trypsin, chymotrypsin and proteinase K. Based on protease inhibitor activity 3 isolates were chosen for further studies. The potential isolate was characterized by polyphasic approach and identified as Streptomyces sp LK3 (JF710608). The lead compound was identified as peptide from Streptomyces sp LK3. The double-reciprocal plot displayed inhibition mode is non-competitive and it confirms the irreversible nature of protease inhibitor. The peptide from Streptomyces sp LK3 extract showed significant anti plasmodial activity (IC50: 25.78 µg/ml). In in vivo model, the highest level of parasitemia suppression (≈ 45%) was observed in 600 mg/kg of the peptide. These analyses revealed no significant changes were observed in the spleen and liver tissue during 8 dpi. The results confirmed up-regulation of TGF-β and down regulation of TNF-α in tissue and serum level in PbA infected peptide treated mice compared to PbA infection. The results obtained infer that the peptide possesses anti- Pf activity activity. It suggests that the extracts have novel metabolites and could be considered as a potential source for drug development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Weltgesundheitsorganisation (2005) · Cited by 3,799
Artemisinin Resistance in Plasmodium falciparum Malaria
Dondorp, A. M., Nosten, F., Yi, P., Das, D., Phyo, A. P., Tarning, J., Lwin, K. M., Ariey, F., Hanpithakpong, W., Lee, S. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808859 · Cited by 3,424
Natural protein proteinase inhibitors and their interaction with proteinases
BODE, W., & HUBER, R. (1992) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1992.tb16654.x · Cited by 1,043
Antimalarial drug discovery: efficacy models for compound screening
Fidock, D. A., Rosenthal, P. J., Croft, S. L., Brun, R., & Nwaka, S. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1416 · Cited by 861
Cysteine proteases of parasitic organisms
Sajid, M., & McKerrow, J. H. (2002) · Molecular and Biochemical Parasitology · doi:10.1016/s0166-6851(01)00438-8 · Cited by 794
Malaria : parasite biology, pathogenesis, and protection
Sherman, I. W. (1998) · ASM Press eBooks · Cited by 760
Emerging principles in protease-based drug discovery
Drag, M., & Salvesen, G. S. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3053 · Cited by 601
Protein docking using spherical polar Fourier correlations
Ritchie, D. W., & Kemp, G. J. L. (2000) · Proteins: Structure, Function, and Genetics · doi:10.1002/(sici)1097-0134(20000501)39:2<178::aid-prot8>3.0.co;2-6 · Cited by 563
THE PROTEASES AND PATHOGENICITY OF PARASITIC PROTOZOA
McKerrow, J. H., Sun, E., Rosenthal, P. J., & Bouvier, J. (1993) · Annual Review of Microbiology · doi:10.1146/annurev.mi.47.100193.004133 · Cited by 385
Yeoh, S., O'Donnell, R. A., Koussis, K., Dluzewski, A. R., Ansell, K. H., Osborne, S. A., Hackett, F., Withers-Martinez, C., Mitchell, G. H., Bannister, L. H., et al. (2007) · Cell · doi:10.1016/j.cell.2007.10.049 · Cited by 357
Cited by
Enhancing autophagy in Alzheimer's disease through drug repositioning
Eshraghi, M., Ahmadi, M., Afshar, S., Lorzadeh, S., Adlimoghaddam, A., Rezvani Jalal, N., West, R., Dastghaib, S., Igder, S., Torshizi, S. R. N., et al. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108171 · Cited by 89
Thakkar, A., & Chaudhari, K. (2020) · Applied Soft Computing · doi:10.1016/j.asoc.2020.106684 · Cited by 88
Toxoplasma gondii vaccine candidates: a concise review
Mamaghani, A. J., Fathollahi, A., Arab-Mazar, Z., kohansal, K., Fathollahi, M., Spotin, A., Bashiri, H., & Bozorgomid, A. (2023) · Irish Journal of Medical Science (1971 -) · doi:10.1007/s11845-022-02998-9 · Cited by 51
Arunachalam, K., Pandurangan, P., Shi, C., & Lagoa, R. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15020310 · Cited by 48
Metadata
- Authors
- Karthik, L., Kumar, G., Keswani, T., Bhattacharyya, A., Chandar, S. S., & Bhaskara Rao, K. V.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2014-03-11
- Volume
- 9
- Issue
- 3
- Pages
- e90972
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2002608402
- Cited by
- 312
- References
- 31
- FWCI
- 3.46
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Protease Inhibitors from Marine Actinobacteria as a Potential Source for Antimalarial Compound. https://app.cochat.ai/papers/10.1371/journal.pone.0090972
- The paper
- Karthik, L., Kumar, G., Keswani, T., Bhattacharyya, A., Chandar, S. S., & Bhaskara Rao, K. V. (2014). Protease Inhibitors from Marine Actinobacteria as a Potential Source for Antimalarial Compound. PLoS ONE. https://doi.org/10.1371/journal.pone.0090972
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.